Insider Trading & Executive Data
Start Free Trial
95 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
AMN Healthcare Services Inc. is a U.S.-focused provider of total talent solutions for healthcare, combining traditional staffing (travel and local nurses/allied, locum tenens physicians, interim/ executive leadership, permanent placement) with technology-enabled workforce services (MSP, VMS, scheduling/predictive analytics, RPO, revenue cycle, language interpretation). In 2024 AMN operated three reportable segments—Nurse & Allied, Physician & Leadership, and Technology & Workforce—and managed roughly $4.0 billion of spend under management across MSP and VMS products, with a meaningful customer concentration (Kaiser ~16% of revenue). The company has been pivoting toward recurring, tech-enabled revenue (WorkWise, ShiftWise Flex, Smart Square, Televate, AMN Passport) to reduce cyclicality, but recently reported material top-line weakness, margin compression, large goodwill impairments and a net loss driven by post‑COVID demand shifts, visa constraints, and pricing pressure. Liquidity remains available via operating cash flow and a revolver, but leverage, impairments and seasonality are material near‑term risks.
Compensation at AMN is likely tied closely to short‑term operational metrics (revenue, gross margin or bill-rate mix, days filled/clinician traveler counts) and to longer‑term financial health measures (adjusted EBITDA, free cash flow, net leverage and recurring SaaS/MSP/VMS penetration). Given management commentary and recent cost discipline, short‑term incentive payouts have been reduced by lower variable compensation, while long‑term equity (RSUs/PSUs) and performance‑based awards are probable tools to retain executives and align them to multi‑year goals such as increasing recurring revenue, expanding MSP/VMS spend under management, and integrating acquisitions. Sector norms in Healthcare/Medical Care Facilities favor a mix of base salary + cash bonuses tied to operating targets and equity that vests over several years; sales and operations leaders often receive commission/production pay tied to placements, fill rates and client wins. Recent goodwill impairments, amended leverage covenants and weak stock performance can trigger compensation plan recalibration (reduced bonuses, modified targets, retention awards) and heighten use of clawbacks or discretion in awarding payouts.
Insider activity at AMN can be informative because the business is sensitive to predictable drivers (traveler counts, visa cycles, seasonal travel nursing demand), high‑impact items (large MSP/VMS contract wins or losses, Kaiser concentration events), and episodic shocks (goodwill/intangible impairments, credit‑agreement amendments). Expect heightened insider caution and more trades under structured 10b5‑1 plans around earnings releases and material events; look for concentration of sales before or after impairment announcements, guidance changes, or covenant tweaks as potential signals. Regulatory and sector constraints — state licensure, immigration/visa policy developments, wage/hour litigation exposure and healthcare compliance — increase the materiality of nonpublic information, narrowing safe trading windows and raising the likelihood of blackouts. For traders and researchers, monitor timing and size of insider exercises versus open‑market disposals, purchases linked to retention packages, and any clustering of trades around quarter ends, major contract renewals, M&A disclosures, or liquidity events.